Company
Board Member
2022-11-10–present
Scott Brun, M.D.
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Scott Brun, M.D.
The company reported in an 8-K filed June 2, 2026 that Scott Brun, M.D. was appointed Class III Director, effective May 29, 2026. The company reported in an 8-K filed November 14, 2022 that Scott Brun, M.D. was appointed Class II director, effective November 10, 2022.
“The following nominees were elected to serve as Class III directors, each to hold office until the Company’s 2029 annual meeting of stockholders or until his respective successor has been duly elected and qualified or his or her earlier resignation or removal:”
“On November 10, 2022, the Board of Directors (the "Board) of the Company, upon recommendation of the Nominating and Governance Committee of the Board, appointed Scott Brun, M.D. to the Board, effective November 10, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2026-05-29–present
-
Organization not stated
SEC 8-K
Current2022-11-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Appointed: Class III Director
-
Executive change Appointed: Class II director